IL6 and multiple sclerosis: showed increased levels in the gut of patients with multiple sclerosis [51] and end-stage renal disease [52], represented a higher positive rate in the ileum of Crohn’s disease patients compared with the healthy control group [53], and reflected a positive correlation with pro-inflammatory cytokine IL-6 [54].